Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP665538.RACmqta90v2Dftut4u4t0AWiJOuz7ya2H44CXJxG0XNdQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP665538.RACmqta90v2Dftut4u4t0AWiJOuz7ya2H44CXJxG0XNdQ130_assertion type Assertion NP665538.RACmqta90v2Dftut4u4t0AWiJOuz7ya2H44CXJxG0XNdQ130_head.
- NP665538.RACmqta90v2Dftut4u4t0AWiJOuz7ya2H44CXJxG0XNdQ130_assertion wasGeneratedBy ECO_0000203 NP665538.RACmqta90v2Dftut4u4t0AWiJOuz7ya2H44CXJxG0XNdQ130_provenance.
- NP665538.RACmqta90v2Dftut4u4t0AWiJOuz7ya2H44CXJxG0XNdQ130_assertion wasDerivedFrom befree-20150227 NP665538.RACmqta90v2Dftut4u4t0AWiJOuz7ya2H44CXJxG0XNdQ130_provenance.
- NP665538.RACmqta90v2Dftut4u4t0AWiJOuz7ya2H44CXJxG0XNdQ130_assertion SIO_000772 25088254 NP665538.RACmqta90v2Dftut4u4t0AWiJOuz7ya2H44CXJxG0XNdQ130_provenance.
- NP665538.RACmqta90v2Dftut4u4t0AWiJOuz7ya2H44CXJxG0XNdQ130_assertion evidence source_evidence_literature NP665538.RACmqta90v2Dftut4u4t0AWiJOuz7ya2H44CXJxG0XNdQ130_provenance.
- NP665538.RACmqta90v2Dftut4u4t0AWiJOuz7ya2H44CXJxG0XNdQ130_assertion description "[All-trans retinoic acid (atRA) treatment is the standard drug treatment for APL yielding cure rates > 80% by activating transcription and proteasomal degradation of retinoic acid receptor, alpha (RARα).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665538.RACmqta90v2Dftut4u4t0AWiJOuz7ya2H44CXJxG0XNdQ130_provenance.